Document Pharma Pharmaceutical manufacturing 
European Pharmaceutical Review
AUGUST 23, 2022
Of the cGMP letters, three major types of violations – deficiencies in process validation, documentation practices (data integrity) and quality control – accounted for 26 percent, 21 percent and 15 percent of warning letters respectively. Overall, validation, documentation and quality control were the major cGMP violations.
Pharma Pathway
JANUARY 27, 2023
Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 28th Jan’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!!
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Pathway
JANUARY 3, 2023
Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 7th Jan’ 2023. Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!! Job Description.
Impetus Digital
AUGUST 2, 2024
Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology. Supply Chain Management Due to geopolitical and climate-related challenges , Pharma supply chain disruptions are becoming increasingly common and complex.
Pharma Pathway
FEBRUARY 3, 2023
APL Health Care (Aurobindo )-Walk-In Interviews for IPQA/ Microbiology On 4th Feb’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Greetings from Aurobindo !!!
pharmaphorum
DECEMBER 28, 2022
M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.
European Pharmaceutical Review
JULY 18, 2023
A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. What is driving adoption of quality management systems in pharma? billion by 2030.
Expert insights. Personalized for you.
105 
Let's personalize your content